Target intelligence / Profile preview

COL18A1 antisense RNA 2 (COL18A1-AS2)

Target
COL18A1-AS2
Molecular classification
Other (long non-coding RNA)
01

Overview

COL18A1 antisense RNA 2 (COL18A1-AS2) is annotated as a long non-coding RNA gene near the COL18A1 locus, but there is extremely limited published scientific information about its molecular function, expression pattern, or clinical relevance[7]. Existing resources such as GeneCards and Harmonizome provide basic gene metadata but do not associate COL18A1-AS2 with any known protein products, biological pathways, disease phenotypes, or drug interactions[7]. In contrast, closely related genes such as COL18A1 protein, and COL18A1-AS1, another lncRNA in the same locus, have established functional roles and disease associations (e.g., COL18A1-AS1 is implicated in cancer and ceRNA networks)[2][10], but these cannot be inferred for COL18A1-AS2. Therefore, COL18A1-AS2 is not considered a validated therapeutic target, nor does it fit standard molecular classifications (receptor, enzyme, etc.), and its significance remains uncharacterized in current biomedical literature[7]. If detailed functional, disease, or therapeutic association information is required, the more established COL18A1 and COL18A1-AS1 genes should be considered for further structured data extraction instead[2][3][10].

Other names
COL18A1 antisense RNA 2 (non-protein coding)COL18A1-AS2
02

Biological functions

Other (no confirmed biological function)

Beyond the preview

Go deeper on COL18A1 antisense RNA 2 (COL18A1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COL18A1 antisense RNA 2 (COL18A1-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call